GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (BOM:530549) » Definitions » Revenue

Shilpa Medicare (BOM:530549) Revenue : ₹12,140 Mil (TTM As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Shilpa Medicare Revenue?

Shilpa Medicare's revenue for the three months ended in Sep. 2024 was ₹3,438 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹12,140 Mil. Shilpa Medicare's Revenue per Share for the three months ended in Sep. 2024 was ₹35.07. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹132.05.

Warning Sign:

Shilpa Medicare Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Shilpa Medicare was 3.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Shilpa Medicare's highest 3-Year average Revenue per Share Growth Rate was 40.30% per year. The lowest was 1.10% per year. And the median was 8.80% per year.


Shilpa Medicare Revenue Historical Data

The historical data trend for Shilpa Medicare's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare Revenue Chart

Shilpa Medicare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,988.75 9,001.59 11,400.49 10,434.46 11,508.37

Shilpa Medicare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,129.77 2,864.82 2,912.04 2,925.11 3,437.97

Competitive Comparison of Shilpa Medicare's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Revenue distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Revenue falls into.



Shilpa Medicare Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹12,140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shilpa Medicare  (BOM:530549) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Shilpa Medicare Revenue Related Terms

Thank you for viewing the detailed overview of Shilpa Medicare's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines